Cancer

HiberCell, Biodesix Partner on ELISA CDx for Cancer Immunotherapy

Through this agreement, Biodesix will develop a companion diagnostic to select patients for enrollment in HiberCell’s future registrational clinical trials.

Cancer

Qlucore Awarded Grant to Aid Clinical Diagnostics of Cancer

The grant will allow Qlucore to expand Qlucore Diagnostics software with a focus on RNA-profiling of glioma and acute leukemia.

Cancer

Liquid Biopsies Guide Improved Cancer Treatment

Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.

‘Pinprick’ Biomarker Blood Test Offers Diagnostic Potential for HPV-Related Cancers

Nov 19, 2020 | Cervical (HPV), Point-of-Care

The new point-of-care biomarker test detects levels of a specific antibody (DRH1) to HPV16. The study shows a link between rising levels of these HPV antibodies and cancer.

Diagnostic Method Predicts Which Cancer Patients Will Respond to Immunotherapy

Nov 17, 2020 | Cancer, Microscopy

The predictive tool was developed using an advanced microscopy platform that identifies the interactions between the immune cells and the tumor cells.

BioAffinity Automated Flow Cytometry Test Detects Lung Cancer in Sputum

Nov 17, 2020 | Flow Cytometry, Lung Cancer

The test validation trial resulted in CyPath Lung specificity of 88% and sensitivity of 82%, similar to far more invasive procedures currently used to diagnose lung cancer.

Hologic’s Genius Digital Diagnostics System for Cervical Cancer Screening Receives CE Mark

Nov 17, 2020 | Cervical (HPV), Cytology, Digital Pathology

Genius Digital Diagnostics is the first digital cytology platform to combine a new artificial intelligence algorithm with advanced digital imaging to help identify precancerous lesions and cancer cells.

Research Detects HULLK in Prostate Cancer

Nov 13, 2020 | Prostate, Research, Urinalysis & Toxicology

The study data provides a potential new approach to early detection of prostate cancer and an alternative to invasive biopsies.

FDA Approves Pan Tumor Liquid Biopsy Test to ID Patients for Treatment with Lynparza

Nov 13, 2020 | Cancer, Molecular Diagnostics

FoundationOne Liquid CDx Identifies Patients with BRCA1, BRCA2, and/or ATM alterations in metastatic castration-resistant prostate cancer (mCRPC) who may be appropriate for treatment with Lynparza.

Medicare Coverage of StrataNGS for Patients with Advanced Solid Tumors

Nov 2, 2020 | Cancer, Molecular Diagnostics

A Medicare administrative contractor has established coverage of the StrataNGS test for patients with advanced stages (III or IV), recurrent, relapsed, refractory, and/or metastatic solid tumors.

FDA Approves First CDx for Expanded EGFR TKI Therapies in NSCLC Patients

Oct 30, 2020 | Lung Cancer

The group claim will also enable the test to be used as a CDx for any future approved EGFR TKI therapies targeting the same mutations.

Prototype Device Lets Patients Monitor Their Own Blood for Cancer Biomarkers

Oct 28, 2020 | Cancer, POC Instruments

The handheld device works much like blood sugar monitors and can be used at home to measure a biomarker for cancer.

FDA Approves New FoundationOne Liquid CDx Companion Diagnostic Indications for 3 Cancer Therapies

Oct 27, 2020 | Breast, Lung Cancer, Unknown Origin & Other Cancer Types

FDA approved FoundationOne Liquid CDx for three new companion diagnostic indications: Piqray in advanced or metastatic breast cancer; Rubraca in advanced ovarian cancer; and Alecensa in a certain type of metastatic non-small cell lung cancer.

Covid-19 Outbreaks Led to Dangerous Delay in Cancer Diagnoses

Oct 26, 2020 | Cancer, Covid 19

Data show a sharp trend of skipping preventive cancer screenings during the covid-19 pandemic, resulting in delayed cancer diagnoses and most likely more cancer deaths.

FDA Approves FoundationOne CDx as Companion Diagnostic to Detect NTRK Fusions Across All Solid Tumors

Oct 24, 2020 | Cancer, Molecular Diagnostics

The tissue-based comprehensive genomic profiling test is currently approved as a companion diagnostic for more than 20 targeted therapies.

Breakthrough Blood Test Developed for Brain Tumors

Oct 23, 2020 | Molecular Diagnostics, Unknown Origin & Other Cancer Types

Research shows a noninvasive ddPCR test can help physicians diagnose and monitor the clinical progress of patients with gliomas.

GenomOncology Pathology Workbench Now Optimized for Higher Throughput

Oct 22, 2020 | Cancer, Digital Pathology

The new solution is optimized for larger panels, higher sample throughput, and the interpretation of copy numbers and structural variants by next generation sequencing.

Study Demonstrates New Tool for Rapid Evaluation of Acute Leukemia Patients

Oct 19, 2020 | Hematology Instrumentation, Leukemia

PixCell’s HemoScreen may be used to monitor pathological blood samples, improving treatment process for hematological patients.

Category: Cancer

Cancer

Cancer

Cancer